Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Functional characterization of the biogenic amine transporters on human macrophages
Phillip M. Mackie, Adithya Gopinath, Dominic M. Montas, Alyssa Nielsen, Aidan Smith, Rachel A. Nolan, Kaitlyn Runner, Stephanie M. Matt, John McNamee, Joshua E. Riklan, Kengo Adachi, Andria Doty, Adolfo Ramirez-Zamora, Long Yan, Peter J. Gaskill, Wolfgang J. Streit, Michael S. Okun, Habibeh Khoshbouei
Phillip M. Mackie, Adithya Gopinath, Dominic M. Montas, Alyssa Nielsen, Aidan Smith, Rachel A. Nolan, Kaitlyn Runner, Stephanie M. Matt, John McNamee, Joshua E. Riklan, Kengo Adachi, Andria Doty, Adolfo Ramirez-Zamora, Long Yan, Peter J. Gaskill, Wolfgang J. Streit, Michael S. Okun, Habibeh Khoshbouei
View: Text | PDF
Research Article Inflammation Neuroscience

Functional characterization of the biogenic amine transporters on human macrophages

  • Text
  • PDF
Abstract

Monocyte-derived macrophages (MDMs) are key players in tissue homeostasis and diseases regulated by a variety of signaling molecules. Recent literature has highlighted the ability for biogenic amines to regulate macrophage functions, but the mechanisms governing biogenic amine signaling in and around immune cells remain nebulous. In the CNS, biogenic amine transporters are regarded as the master regulators of neurotransmitter signaling. While we and others have shown that macrophages express these transporters, relatively little is known of their function in these cells. To address these knowledge gaps, we investigated the function of norepinephrine transporter (NET) and dopamine transporter (DAT) on human MDMs. We found that both NET and DAT are present and can uptake substrate from the extracellular space at baseline. Not only was DAT expressed in cultured MDMs, but it was also detected in a subset of intestinal macrophages in situ. Surprisingly, we discovered a NET-independent, DAT-mediated immunomodulatory mechanism in response to LPS. LPS induced reverse transport of dopamine through DAT, engaging an autocrine/paracrine signaling loop that regulated the macrophage response. Removing this signaling loop enhanced the proinflammatory response to LPS. Our data introduce a potential role for DAT in the regulation of innate immunity.

Authors

Phillip M. Mackie, Adithya Gopinath, Dominic M. Montas, Alyssa Nielsen, Aidan Smith, Rachel A. Nolan, Kaitlyn Runner, Stephanie M. Matt, John McNamee, Joshua E. Riklan, Kengo Adachi, Andria Doty, Adolfo Ramirez-Zamora, Long Yan, Peter J. Gaskill, Wolfgang J. Streit, Michael S. Okun, Habibeh Khoshbouei

×

Figure 2

Human monocyte-derived macrophages express DAT and NET that are localized to the plasma membrane.

Options: View larger image (or click on image) Download as PowerPoint
Human monocyte-derived macrophages express DAT and NET that are localize...
(A) Representative immunoblots for NET and DAT from macrophage intracellular and membrane fractions separated via biotinylation assay (splice sites indicated by solid lines). (B) Representative 40× total internal reflective fluorescence microscopy (TIRF-M) images of cultured macrophages labeled with CTxB-555 and either NET or DAT antibodies. CTxB-555 punctae appeared on the basal membrane, along with scattered punctae of NET (top) and DAT (bottom). Some punctae of CTxB colocalized with NET or DAT (arrowheads, n = 4 experiments). (C and D) Representative confocal images (C, n = 4 experiments) or stimulated emission depletion (STED) images (D, n = 2 experiments) on cultured human macrophages labeled with CTxB-555 and for DAT with some of the DAT signal colocalizing with the CTxB-555 signal at or near the membrane. (E) Schematic of the experimental design for JHC1-064 binding assay to identify NET-specific and DAT-specific binding. (F and G) Live-cell confocal (60×) and TIRF-M (40×) images of JHC1-064 binding to macrophages in conditions shown in E. (H) Quantifying the JHC1-064 signal from F shows that blocking NET or DAT decreased JHC1-064 binding. Blocking both transporters further decreased the JHC1-064 signal on macrophages (2-way ANOVA with Tukey’s test for multiple comparisons, P < 0.05). (I and J) The magnitude (I) and rate (J) of JHC1-064 binding to human macrophages were decreased by the addition of Nom or DMI. (I) Control versus DAT-specific (P < 0.0001), control versus NET-specific (P < 0.0001). (J) Control versus DAT-specific (P = 0.0004), control versus NET-specific (P < 0.0001). Blocking all 3 transporters further decreased the magnitude (I, P < 0.0001) and rate (J, P < 0.0001) of JHC1-064 binding. Images and data in F–J are from n = 114–157 cells/group from 3 independent experiments. Statistical analysis in I and J performed by Kruskal-Wallis test with Dunn’s test for multiple comparisons.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts